DRREDDY.NS Cash Flow
Dr. Reddy's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | N/A | N/A | N/A | ₹28.11 Bn | ₹58.87 Bn | ₹45.43 Bn | ₹46.43 Bn | ₹56.74 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | N/A | N/A | N/A | ₹-26.39 Bn | ₹-41.37 Bn | ₹-40.28 Bn | ₹-51.02 Bn | ₹-65.49 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | N/A | N/A | N/A | ₹-2.42 Bn | ₹-26.86 Bn | ₹-3.76 Bn | ₹11.86 Bn | ₹8.29 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | N/A | N/A | N/A | ₹0.73 Bn | ₹0.29 Bn | ₹-0.06 Bn | ₹0.22 Bn | ₹1.24 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | N/A | N/A | N/A | ₹0.03 Bn | ₹-9.07 Bn | ₹1.33 Bn | ₹7.49 Bn | ₹0.78 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | N/A | N/A | N/A | ₹14.82 Bn | ₹14.85 Bn | ₹5.78 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from DRREDDY.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).